| PERIOD ENDING | 28-Feb-09 | 29-Nov-08 | 30-Aug-08 | 31-May-08 | | Total Revenue | 14,724,000 | 11,500,000 | 9,801,000 | 8,990,000 | | Cost of Revenue | 11,101,000 | 8,639,000 | 7,420,000 | 6,857,000 | | | Gross Profit | 3,623,000 | 2,861,000 | 2,381,000 | 2,133,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,499,000 | 2,587,000 | 2,042,000 | 1,856,000 | | Non Recurring | 144,000 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 980,000 | 274,000 | 339,000 | 277,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | (114,000) | 9,000 | 21,000 | | Earnings Before Interest And Taxes | 988,000 | 160,000 | 348,000 | 298,000 | | Interest Expense | 25,000 | 35,000 | 21,000 | 13,000 | | Income Before Tax | 963,000 | 125,000 | 327,000 | 285,000 | | Income Tax Expense | 378,000 | 68,000 | 122,000 | 106,000 | | Minority Interest | (17,000) | (11,000) | (3,000) | 1,000 | | | | Net Income From Continuing Ops | 570,000 | 52,000 | 202,000 | 179,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 570,000 | 52,000 | 202,000 | 179,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $570,000 | $52,000 | $202,000 | $179,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
